Metabolomic signature of type 1 diabetes-induced sensory loss and nerve damage in diabetic neuropathy
Diabetic-induced peripheral neuropathy (DPN) is a diabetic late complication. The molecular mechanisms underlying the pathophysiology of nerve damage & sensory loss remain largely unclear. Recently, alterations in metabolic flux have gained attention a basis for organ damage in diabetes; however, peripheral sensory neurons have not been adequately analyzed. In the present study, we attempted to delineate the role of alteration of metabolic pathways in relation to nerve damage & sensory loss. We employed STZ-injected mouse model of type1 diabetes. To investigate the progression of DPN by behavioral measurements of sensitivity to thermal & mechanical stimuli and quantitative assessment of intraepidermal nerve fiber density. We employed a MS-based screen to address alterations in levels of metabolites in peripheral sciatic nerve (SN) & amino acids (AA) in serum over several months post-STZ administration. Although hyperglycemia & body weight changes occurred early, sensory loss & reduced intraepithelial branching of nociceptive nerves was only evident at 22 wks post-STZ. The longitudinal metabolites screen in SN demonstrated that mice at 12 and 22 wks post-STZ showed an early impairment the tricarboxylic acid. We found that levels of citric acid, ketoglutaric acid, succinic acid, fumaric acid & malic acid were observed to be significantly reduced in SN at 22 wks post-STZ. In addition, we also found the increase in levels of sorbitol & L-Lactate in SN from 12 wks post-STZ injection. AA screen in serum showed that the amino acids Val, Ile and Leu, increased more than 2-fold from 12 wks post-STZ. Similarly, the levels of Tyr, Asn, Ser, His, Ala, & Pro showed progressive increase. Our results indicate that the impaired TCA cycle metabolites in peripheral nerve is the primary cause of shunting metabolic substrate to compensatory pathways which leads to mitochondrial dysfunction & nerve damage.
Code (0)
등록된 구현이 없습니다.
Similar Papers 제목 키워드 기반
Hypoxia-inducible factor 1a protects peripheral sensory neurons from diabetic peripheral neuropathy by suppressing accumulation of reactive oxygen species
Diabetic peripheral neuropathy (DPN) is one of the most common diabetic complications. Mechanisms underlying nerve damage and sensory loss following metabolic dysfunction remain large unclear. Recently, hyperglycemia-ind…
Bioinformatics Analysis of Metabolomics Data Unveils Association of Metabolic Signatures with Methylation in Breast Cancer
Breast cancer (BC) contributes the highest global cancer mortality in women. BC tumors are highly heterogeneous, so subtyping by cell-surface markers is inadequate. Omics-driven tumor stratification is urgently needed to…
Data-Driven Abdominal Phenotypes of Type 2 Diabetes in Lean, Overweight, and Obese Cohorts
Purpose: Although elevated BMI is a well-known risk factor for type 2 diabetes, the disease's presence in some lean adults and absence in others with obesity suggests that detailed body composition may uncover abdominal …
Metabolomic Biomarker Discovery for ADHD Diagnosis Using Interpretable Machine Learning
Attention Deficit Hyperactivity Disorder (ADHD) is a prevalent neurodevelopmental disorder with limited objective diagnostic tools, highlighting the urgent need for objective, biology-based diagnostic frameworks in preci…
Interpretable Machine LearningPredicting Gene Disease Associations in Type 2 Diabetes Using Machine Learning on Single-Cell RNA-Seq Data
Diabetes is a chronic metabolic disorder characterized by elevated blood glucose levels due to impaired insulin production or function. Two main forms are recognized: type 1 diabetes (T1D), which involves autoimmune dest…